Literature DB >> 23151828

Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.

Youn Ah Choi1, Chan Kyo Kim, Byung Kwan Park, Bohyun Kim.   

Abstract

PURPOSE: To retrospectively compare absolute and relative washout of adrenal metastases in patients with renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC) to that of adrenal adenoma.
MATERIALS AND METHODS: Between November 1994 and August 2011, in this institutional review board-approved study (with waiver of informed consent), 16 patients with 19 adrenal metastases (16 in 13 RCC patients, three in three HCC patients) and 20 patients with 21 adrenal adenomas (16 in 15 RCC patients, five in five HCC patients) underwent dedicated adrenal protocol consisting of unenhanced, 1-minute contrast material-enhanced, and 15-minute delayed contrast-enhanced computed tomography (CT). The attenuation values and percentage enhancement washout, including absolute percentage washout (APW) and relative percentage washout (RPW), were calculated. If available, histologic findings and the change in the size of adrenal lesions were assessed. Statistical analyses were performed by using generalized estimating equation and coefficient of variation.
RESULTS: The mean APW of the metastases (observer 1, 67% ± 11 [standard deviation]; observer 2, 63% ± 12) was not significantly different from that of adenomas (observer 1, 73% ± 9; observer 2, 72% ± 12) for observer 1 (P = .143) and was significantly different for observer 2 (P = .029). The mean RPW of the metastases (observer 1, 46% ± 11; observer 2, 43% ± 12) was significantly lower than that of adenomas (observer 1, 62% ± 19; observer 2, 60% ± 17) (all P < .001 for each observer). With a threshold of 60% for APW or 40% for RPW, 95% (18 of 19) and 89% (17 of 19), respectively, of the metastases were falsely diagnosed as lipid-poor adenomas by each observer. All nine metastases that were followed up at CT had a substantial growth in size.
CONCLUSION: In patients with RCC and HCC who undergo dedicated adrenal CT imaging for known adrenal lesions, the percentage enhancement washout of adrenal metastases is similar to that of lipid-poor adrenal adenomas. Careful imaging follow-up or pathologic tissue confirmation is needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151828     DOI: 10.1148/radiol.12120110

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

Review 1.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

2.  The role of percutaneous CT-guided biopsy of an adrenal lesion in patients with known or suspected lung cancer.

Authors:  E McDermott; A Kilcoyne; A O'Shea; A M Cahalane; S McDermott
Journal:  Abdom Radiol (NY)       Date:  2020-09-18

3.  Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma.

Authors:  Nicola Schieda; Matthew S Davenport; Ivan Pedrosa; Atul Shinagare; Hersch Chandarana; Nicole Curci; Ankur Doshi; Gary Israel; Erick Remer; Jane Wang; Stuart G Silverman
Journal:  J Magn Reson Imaging       Date:  2019-01-28       Impact factor: 4.813

Review 4.  Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.

Authors:  Jung Jae Park; Byung Kwan Park; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2016-03-02       Impact factor: 3.039

5.  Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas.

Authors:  Wendy Tu; Jorge Abreu-Gomez; Amar Udare; Abdulmohsen Alrashed; Nicola Schieda
Journal:  Radiol Imaging Cancer       Date:  2020-10-30

6.  Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria.

Authors:  Sohi Kang; Young Lyun Oh; Sung Yoon Park
Journal:  Abdom Radiol (NY)       Date:  2020-09-20

7.  Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.

Authors:  Wendy Tu; Rosalind Gerson; Jorge Abreu-Gomez; Amar Udare; Rachel Mcphedran; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-06-12

Review 8.  Virtual or real: lifelike cinematic rendering of adrenal tumors.

Authors:  Lei Tang; Yuquan Wang; Xiushu Yang; Guangheng Luo; Xianchun Zeng; Rongpin Wang; Bin Song
Journal:  Quant Imaging Med Surg       Date:  2021-08

9.  MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence.

Authors:  Stephanie F Coquia; Pamela T Johnson; Sameer Ahmed; Elliot K Fishman
Journal:  World J Radiol       Date:  2013-11-28

10.  The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.

Authors:  Hyun Jung Koo; Hyuck Jae Choi; Hwa Jung Kim; Sun-Ok Kim; Kyoung-Sik Cho
Journal:  Eur Radiol       Date:  2014-03-20       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.